•  11
    A Public Health Ethics Framework for Populations with Limited English Proficiency
    with Samantha A. Chipman and Amelia K. Barwise
    American Journal of Bioethics 1-16. forthcoming.
    Abstract25.6 Million people in the United States have Limited English Proficiency (LEP), defined as insufficient ability to read, write, or understand English. We will (1) Delineate the merits of approaching language as a social determinant of health, (2) highlight pertinent public health values and guidelines which are most relevant to the plight of populations with LEP and (3) Use the COVID-19 pandemic as an example of how a breakdown in public health ethics values created harm for populations…Read more
  •  15
    Translational Justice in Human Gene Editing: Bringing End User Engagement and Policy Together
    with Megan A. Allyse, Marsha Michie, Rosario Isasi, Kelly E. Ormond, Natasha Bonhomme, Yvonne Bombard, Heidi Howard, Kiran Musunuru, Kirsten A. Riggan, and Sabina Rubeck
    American Journal of Bioethics 23 (7): 55-58. 2023.
    In their target article, Conley et al. (2023) appropriately highlight the ongoing conceptual and practical opacity of public engagement (PE) in the translation of human gene editing (HGE) (Conley e...
  •  17
    The Slippery Slope of Prenatal Testing for Social Traits
    with Courtney Canter, Kathleen Foley, Shawneequa L. Callier, Margaret Waltz, Aurora Washington, R. Jean Cadigan, Anya E. R. Prince, and the Beyond the Medical R01 Research Team
    American Journal of Bioethics 23 (3): 36-38. 2023.
    Bowman-Smart et al. (2023) argue for a framework to examine the ethical issues associated with genetic screening for non-medical traits in the context of noninvasive prenatal testing (NIPT). Such s...
  •  22
    Grammar-Mediated Time-Series Prediction
    with A. Brabazon, E. Carty, M. O'Neill, and P. Keenan
    Journal of Intelligent Systems 14 (2-3): 123-142. 2005.
  •  11
    MacKay’s Public Health Virtue Ethics offers a distinctive approach to public health ethics, with social structures at the forefront. MacKay’s helpful overview of the recent literature considers three distinct referents for ascribing virtues in public health ethics: (i) individuals, such as public health practitioners, (ii) social structures, such as public health institutions and policies and (iii) the communities affected by public health policy. While MacKay is interested in virtuous structure…Read more
  •  9
    Bioethics Theory-Building for Public Health
    American Journal of Bioethics 21 (9): 53-56. 2021.
    I whole-heartedly endorse Ismaili M'hmandi’s efforts to move away from the narrowest of liberal justificatory grounds for public health policy. I worry, however, that the liberal perfectioni...
  •  19
    Bioethics Advocacy in Ethos, Practice and Metrics
    with Amelia K. Barwise, Bjoerg Thorsteinsdottir, Megan A. Allyse, and Michelle J. Clarke
    American Journal of Bioethics 21 (2): 69-72. 2021.
    Bioethicists in healthcare institutions have the skills and insights and can and must facilitate and promote measures that address deeply ingrained structural issues that exacerbate health inequity...
  •  31
    Multiple Marginalizations: What Bioethics Can Learn From Black Feminism
    with Amal W. Cheema and Richard R. Sharp
    American Journal of Bioethics 19 (2): 1-3. 2019.
  •  20
    Grudging Trust and the Limits of Trustworthy Biorepository Curation
    with Eric T. Juengst and Gail E. Henderson
    American Journal of Bioethics 18 (4): 23-25. 2018.
  •  46
    Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
    with Gail E. Henderson, Holly L. Peay, Eugene Kroon, Rosemary Jean Cadigan, Thidarat Jupimai, Adam Gilbertson, Jill Fisher, Nuchanart Q. Ormsby, Nitiya Chomchey, Nittaya Phanuphak, Jintanat Ananworanich, and Stuart Rennie
    Journal of Medical Ethics. 2017.
    Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption, involve uncertain and potentially high risk, with minimal chance of clinical benefit. Some question whether such trials should be offered, given the risk/benefit imbalance, and whether those who choose to participate are actin…Read more
  •  53
    Costa rica's 'white legend': How racial narratives undermine its health care system
    with Lisa Campo-Engelstein
    Developing World Bioethics 11 (2): 99-107. 2011.
    A dominant cultural narrative within Costa Rica describes Costa Ricans not only as different from their Central American neighbours, but it also exalts them as better: specifically, as more white, peaceful, egalitarian and democratic. This notion of Costa Rican exceptionalism played a key role in the creation of their health care system, which is based on the four core principles of equity, universality, solidarity and obligation. While the political justification and design of the current healt…Read more
  •  16
    Present Lessons from Past Infractions
    with Kayte Spector-Bagdady
    Teaching Ethics 14 (2): 53-76. 2014.
  •  34
    Contemporary Debates in Applied Ethics (review)
    Teaching Philosophy 29 (4): 365-367. 2006.
  •  42
    Considering virtue: public health and clinical ethics
    Journal of Evaluation in Clinical Practice 17 (5): 888-893. 2011.